Sophie Gautier
Université Lille Nord de France(FR)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Practices and Patient Outcomes, Acute Ischemic Stroke Management, Drug-Induced Adverse Reactions, Pharmaceutical studies and practices
Most-Cited Works
- → PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases(2006)271 cited
- → Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes(2015)213 cited
- → Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database(2016)177 cited
- → Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial(2018)147 cited
- → Zoledronic Acid and Renal Toxicity: Data from French Adverse Effect Reporting Database(2005)80 cited
- → The cost of adverse drug reactions(2003)70 cited
- → Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia(2016)68 cited
- → Effects of the PPAR-α Agonist Fenofibrate on Acute and Short-Term Consequences of Brain Ischemia(2014)68 cited
- → Analysis of the association of MPO and MMP-9 with stroke severity and outcome(2020)67 cited
- → Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia(2009)66 cited